Nutra Pharma Corp. (OTCMKTS:NPHC) To Move Higher

Nutra Pharma Corp. (OTCMKTS:NPHC) To Move Higher






Nutra Pharma Corp. (OTCMKTS:NPHC) To Move Higher NUTRA PHARMA CRP closed unchanged at 0.018. Volume was 24% below average (neutral) and Bollinger Bands were 105% wider than normal. Open High Low Close Volume___ 0.017 0.019 0.015 0.018 814,776 Technical Outlook Short Term: Overbought Intermediate Term: Bullish Long Term: Bullish Moving Averages: 10-period 50-period 200-period Close: […]






Nutra Pharma Corp. (OTCMKTS:NPHC) Ready to Break Out

Nutra Pharma Corp. (OTCMKTS:NPHC) Ready to Break Out






Nutra Pharma Corp. (OTCMKTS:NPHC) Ready to Break Out NUTRA PHARMA CRP closed up 0.002 at 0.014. Volume was 18% below average (neutral) and Bollinger Bands were 16% wider than normal. Open High Low Close Volume___ 0.011 0.014 0.011 0.014 665,534 Technical Outlook Short Term: Neutral Intermediate Term: Bullish Long Term: Bullish Moving Averages: 10-period 50-period […]






Nutra Pharma Corp. (OTCMKTS:NPHC) a BioTech in Multi Billion Dollar Pet Care Business






Nutra Pharma Corp. (OTCMKTS:NPHC) a BioTech in Multi Billion Dollar Pet Care Business Millions of pets suffer from acute or chronic pain. While acute pain is a normal sensation triggered in the nervous system to alert your pet of possible injury and the need to take it easy, chronic pain is different, chronic pain persists. […]






Nutra Pharma Corp. (OTCMKTS:NPHC) Working on HIV and Multiple Sclerosis

Nutra Pharma Corp. (OTCMKTS:NPHC) Working on HIV and Multiple Sclerosis






Nutra Pharma Corp. (OTCMKTS:NPHC) Working on HIV and Multiple Sclerosis This is an interesting BioTech, Nutra Pharma Corp. (OTCMKTS:NPHC) the company has drug candidates in HIV and Multiple Sclerosis as well as an existing Pain Management product. ReceptoPharm (website) is the Nutra Pharma holding that acts as the drug discovery arm for the Company. Nutra […]






Nutra Pharma Corporation (OTCQB:NPHC) Clinical Trials in Multiple Sclerosis

Nutra Pharma Corporation (OTCQB:NPHC) Clinical Trials in Multiple Sclerosis






Nutra Pharma Corporation (OTCQB:NPHC) Clinical Trials in Multiple Sclerosis Nutra Pharma Corporation (OTCQB:NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market, and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, announced a manufacturing alliance today with Omnia Biologics to […]